Literature DB >> 6863909

A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity.

A Clark, C W Potter, R Jennings, J P Nicholl, A F Langrick, G C Schild, J M Wood, D A Tyrrell.   

Abstract

Groups of volunteers were immunized subcutaneously with one of three inactivated influenza virus A/USSR/77 (H1N1) vaccine preparations; a whole virus vaccine, a surface-antigen subunit adsorbed vaccine, or an aqueous surface-antigen subunit vaccine. The reactions to immunization were recorded, and the antibody response was measured 1 month later. A fourth group of volunteers were inoculated intranasally with live attentuated A/USSR/77 (H1N1) influenza virus; the reactions and antibody response of these volunteers were also measured. One month after immunization, the incidence of infection by challenge with homologous live attentuated virus was determined for all groups of volunteers. The results showed that all four vaccines used were relatively non-reactogenic, and that inactivated vaccines induced higher titres of serum antibody than the live attenuated vaccine. All the vaccines induced significant protection against challenge virus infection which was directly related to the level of serum HI antibody response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863909      PMCID: PMC2134273          DOI: 10.1017/s0022172400028989

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic.

Authors:  G MEIKLEJOHN; C H KEMPE; W G THALMAN; E H LENNETTE
Journal:  Am J Hyg       Date:  1952-01

Review 2.  Determinants of immunity to influenza infection in man.

Authors:  C W Potter; J S Oxford
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

3.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

4.  Immunity to influenza in ferrets. VI. Immunization with adjuvanted vaccines.

Authors:  C W Potter; R Jennings; C McLaren
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine.

Authors:  J A Kasel; E B Hume; R V Fulk; Y Togo; M Huber; R B Hornick
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

6.  A single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen. Proposals for an assay method for the haemagglutinin content of influenza vaccines.

Authors:  G C Schild; J M Wood; R W Newman
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

7.  Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccine.

Authors:  F L Ruben; C W Potter; C H Stuart-Harris
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

8.  Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man.

Authors:  B R Murphy; E G Chalhub; S R Nusinoff; J Kasel; R M Chanock
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

9.  A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.

Authors:  M I Brady; I G Furminger
Journal:  J Hyg (Lond)       Date:  1976-10

10.  Reactogenicity and immunogenicity of whole and ether-Tween-split influenza A virus vaccines in volunteers.

Authors:  R Jennings; A Clark; J S Oxford; D J Hockley; C W Potter
Journal:  J Infect Dis       Date:  1978-11       Impact factor: 5.226

View more
  8 in total

1.  A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes.

Authors:  Laurent Coudeville; Philippe Andre; Fabrice Bailleux; Françoise Weber; Stanley Plotkin
Journal:  Hum Vaccin       Date:  2010-10-01

2.  Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles.

Authors:  N L Davis; I J Caley; K W Brown; M R Betts; D M Irlbeck; K M McGrath; M J Connell; D C Montefiori; J A Frelinger; R Swanstrom; P R Johnson; R E Johnston
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.

Authors:  M L Clements; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-01       Impact factor: 5.948

4.  Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis.

Authors:  R Al-Khayatt; R Jennings; C W Potter
Journal:  J Hyg (Lond)       Date:  1984-10

5.  Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model.

Authors:  Laurent Coudeville; Fabrice Bailleux; Benjamin Riche; Françoise Megas; Philippe Andre; René Ecochard
Journal:  BMC Med Res Methodol       Date:  2010-03-08       Impact factor: 4.615

6.  A comparison of live and inactivated influenza A (H1N1) virus vaccines. 2. Long-term immunity.

Authors:  A Clark; C W Potter; R Jennings; J P Nicholl; A F Langrick; G C Schild; J M Wood; D A Tyrrell
Journal:  J Hyg (Lond)       Date:  1983-06

7.  Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature.

Authors:  W E Beyer; A M Palache; A D Osterhaus
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 8.  Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines.

Authors:  Saranya Sridhar; Karl A Brokstad; Rebecca J Cox
Journal:  Vaccines (Basel)       Date:  2015-04-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.